3R gene expression in chronic lymphocytic leukemia reveals insight into disease evolution

S Grgurevic; L Berquet; A Quillet-Mary; G Laurent; C Récher; L Ysebaert; C Cazaux; J S Hoffmann

doi:10.1038/bcj.2016.39

3R gene expression in chronic lymphocytic leukemia reveals insight into disease evolution

Blood Cancer J. 2016 Jun 3;6(6):e429. doi: 10.1038/bcj.2016.39.

Authors

S Grgurevic^{1

2

3

4

5}, L Berquet^{1

2

3}, A Quillet-Mary^{1

2

3

5}, G Laurent^{1

2

3

5

6}, C Récher^{1

2

5

6}, L Ysebaert^{1

2

3

5

6}, C Cazaux, J S Hoffmann^{1

2

3

4

5}

Affiliations

¹ INSERM, U1037, CRCT, Toulouse, France.
² University Toulouse III Paul Sabatier, U1037, CRCT, Toulouse, France.
³ CNRS, ERL5294, CRCT, Toulouse, France.
⁴ Equipe 'Labellisée LA LIGUE CONTRE LE CANCER 2013', Toulouse, France.
⁵ Laboratoire d'Excellence Toulouse Cancer Labex Toucan, CRCT, Inserm U1037, CNRS ERL5294, Toulouse, France.
⁶ Department of Hematology, Institut Universitaire du Cancer (IUC), Toulouse, France.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Aged, 80 and over
Case-Control Studies
Cell Transformation, Neoplastic / genetics
DNA Repair / genetics*
DNA Replication / genetics*
Disease Progression
Female
Gene Expression Regulation, Leukemic
Genes, Neoplasm
Humans
Leukemia, Lymphocytic, Chronic, B-Cell / genetics*
Leukemia, Lymphocytic, Chronic, B-Cell / pathology*
Male
Middle Aged
Recombination, Genetic / genetics*